Ben Snedeker is the Co-Head of Public Equities at Catalio Capital Management, LP and the Portfolio Manager for the Catalio Public Equities Fund.
Prior to joining Catalio, Ben served as the Sector Head for Therapeutics at HealthCor Management, LP, a global healthcare-focused long short equity fund. Over his 15 year public equities career Ben has also been a therapeutics analyst at PointState Capital LP and the portfolio manager for long short healthcare equities at D.E. Shaw & Co., LP. Earlier in his career, Ben was an Associate Principal at McKinsey & Company in the Global Pharmaceuticals and Medical Products Practice and was a founding member of McKinsey’s Philadelphia office.
Ben earned his B.S. degree in Chemistry from The Pennsylvania State University and his M.S. degree in Chemistry from Yale University.